The divergent opinions of regulatory authorities on roflumilast are puzzling but we need new drugs for treating chronic obstructive pulmonary disease

Anzueto, A. , Leimer, I. and Kesten, S. (2009) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis 4: 245-251.

Barnes, P.J. ( 2006) Reduced histone deacetylase in COPD: Clinical implications . Chest 129: 151-155.

Bateman, E.D. , Hurd, S.S. , Barnes, P.J. , Bousquet, J. , Drazen, J.M. , FitzGerald, M. et al. (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31: 143-178.

Boswell-Smith, V. , Cazzola, M. and Page, C.P. ( 2006) Are phosphodiesterase 4 inhibitors just more theophylline ? J Allergy Clin Immunol 11: 1237-1243.

Calverley, P.M. , Rabe, K.F. , Goehring, U.M. , Kristiansen, S. , Fabbri, L.M. and Martinez, F.J. (2009) Roflumilast in symptomatic chronic obstructive pulmonary disease: Two randomised clinical trials. Lancet 374: 685-694.

Calverley, P.M. , Sanchez-Toril, F. , McIvor, A. , Teichmann, P. , Bredenbroeker, D. and Fabbri, L.M. ( 2007) Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176: 154-161.

Cazzola, M. , Bettoncelli, G. , Sessa, E. and Cricelli, C. (2009) Primary care of the patient with chronic obstructive pulmonary disease in Italy. Respir Med 103: 582-588.

Cazzola, M. , Picciolo, S. and Matera, M.G. (2010) Roflumilast in chronic obstructive pulmonary disease: Evidence from large trials. Expert Opin Pharmacother 11: 441-449.

Celli, B.R. ( 2008) What is the best pharmacological treatment to prevent exacerbation of chronic obstructive pulmonary disease? Pol Arch Med Wewn 118: 172-174.

Cosio, B.G. , Tsaprouni, L. , Ito, K. , Jazrawi, E. , Adcock, I.M. and Barnes, P.J. ( 2004) Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 200: 689-695.

Gizycki, M.J. , Hattotuwa, K.L. , Barnes, N. and Jeffery, P.K. ( 2002) Effects of fluticasone propionate on inflammatory cells in COPD: An ultrastructural examination of endobronchial biopsy tissue. Thorax 57: 799-803.

Grootendorst, D.C. , Gauw, S.A. , Verhoosel, R.M. , Sterk, P.J. , Hospers, J.J. , Bredenbröker, D. et al. (2007) Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax 62: 1081-1087.

Ito, K. , Ito, M. , Elliott, W.M. , Cosio, B. , Caramori, G. , Kon, O.M. et al. (2005) Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352: 1967-1976.

Rabe, K.F. , Bateman, E.D. , O’Donnell, D. , Witte, S. , Bredenbröker, D. and Bethke, T.D. ( 2005) Roflumilast - an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: A randomised controlled trial. Lancet 366: 563-571.

Rabe, K.F. , Hurd, S. , Anzueto, A. , Barnes, P.J. , Buist, S.A. , Calverley, P. et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary . Am J Respir Crit Care Med 176: 532-555.

Rodrigo, G.J. , Castro-Rodriguez, J.A. and Plaza, V. (2009) Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: A systematic review. Chest 136: 1029-1038.

Roy, K. , Smith, J. , Kolsum, U. , Borrill, Z. , Vestbo, J. and Singh, D. ( 2009) COPD phenotype description using principal components analysis. Respir Res 10: 41.

Saha, S. and Brightling, C.E. ( 2006) Eosinophilic airway inflammation in COPD. Int J Chron Obstruct Pulmon Dis 1: 39-47.

Sousa, L.P. , Carmo, A.F. , Rezende, B.M. , Lopes, F. , Silva, D.M. , Alessandri, A.L. et al. (2009) Cyclic AMP enhances resolution of allergic pleurisy by promoting inflammatory cell apoptosis via inhibition of PI3K/Akt and NF-kB. Biochem Pharmacol 78: 396-405.

Tattersfield, A.E. , Harrison, T.W. , Hubbard, R.B. and Mortimer, K. ( 2004) Safety of inhaled corticosteroids. Proc Am Thorac Soc 1: 171-175.

To, Y. , Ito, K. , Kizawa, Y. , Failla, M. , Ito, M. , Kusama, T. et al. (2010) Targeting phosphoinositide-3-kinase-δ with theophylline reverses corticosteroid insensitivity COPD. Am J Respir Crit Care Med, doi:10.1164/rccm.200906-0937OC.

Walker, E.P. ( 2010) Panel votes against new PDE4 inhibitor for COPD. Available at http://www.medpagetoday.com/Pulmonology/SmokingCOPD/19448 .

Wedzicha, J.A. and Seemungal, T.A. ( 2007) COPD exacerbations: Defining their cause and prevention . Lancet 370: 786-796.